Abstract 4363206: Electronegative L5 Low-Density Lipoprotein Rapidly Impairs Endothelial Proliferation and Triggers Early Senescence

F Frances Ouyang (The Texas Heart Institute, Houston, Texas, United States) P Patricia Luciana da Costa Lopez (The Texas Heart Institute, Houston, Texas, United States) C Chu-Huang Chen (The Texas Heart Institute, Houston, Texas, United States) O Omer Akyol (The Texas Heart Institute, Houston, Texas, United States) H Huan-Hsing Chiang (The Texas Heart Institute, Houston, Texas, United States) L Logan Butler (The Texas Heart Institute, Houston, Texas, United States) C Camila Hochman Mendez (The Texas Heart Institute, Houston, Texas, United States) D Darren Woodside (The Texas Heart Institute, Houston, Texas, United States) T Thomas Luescher (University of Zurich, Zurich, Switzerland) A Alon Azares (The Texas Heart Institute, Houston, Texas, United States)

Abstract

Background: Electronegative low-density lipoprotein (LDL) subfractions, particularly L5, the most electronegative, have been implicated in endothelial cytotoxicity and atherogenesis. In contrast to L1, the least electronegative subfraction, L5 promotes oxidative stress and endothelial dysfunction.These alterations disturb vascular homeostasis, drive chronic inflammation, and contribute to atherosclerotic progression. However, the specific impact of L5 on endothelial cell proliferation and regeneration remains unclear. Objective: To investigate how the L5 LDL subfraction affects endothelial cell proliferation after short-term exposure. Methods: Bovine aortic endothelial cells (BAECs) were treated for 6 hours with 25 µg/mL of L1, L5, or oxidized LDL, and PBS. Membrane integrity and cellular morphology were assessed using wheat germ agglutinin (WGA) staining, while nuclear area was evaluated via DAPI staining. Apoptosis was quantified using Annexin V/PI staining by flow cytometry. Cell cycle analysis was conducted via PI staining. Western blotting was performed to assess protein expression levels of γH2AX (DNA damage marker) and β-catenin (Wnt signaling and endothelial injury marker). Results: L5 treatment led to mild membrane disruption and abnormal nuclear morphology, with a nuclear area increase of 18% compared to PBS. While apoptosis and cell cycle differences were not statistically significant at 6 hours, an increased sub-G1 population suggested apoptotic activity in L5- and oxLDL-treated cells. Polyploid nuclei were 6 times more frequent in L5 group versus PBS controls. DNA damage, indicated by γH2AX expression, was decreased after L5 and oxLDL exposure. However, β-catenin levels remained unchanged at this early time point. L5 also presented polyploid accumulation, suggesting cell cycle arrest and initiation of senescence. Conclusion: This study shows that short-term exposure to L5 low-density lipoprotein disrupts endothelial proliferation by promoting nuclear abnormalities, apoptosis, and polyploidy, hallmarks of senescence. These effects may impair vascular regeneration and contribute to vascular dysfunction and myocardial ischemia. Our findings provide insight into how LDL electronegativity increases cardiovascular risk independent of total lipid levels. Future studies will explore long-term effects and protective strategies against L5-induced endothelial injury and potential endothelial-to-mesenchymal transition.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (10)

F

Frances Ouyang

The Texas Heart Institute, Houston, Texas, United States

P

Patricia Luciana da Costa Lopez

The Texas Heart Institute, Houston, Texas, United States

C

Chu-Huang Chen

The Texas Heart Institute, Houston, Texas, United States

O

Omer Akyol

The Texas Heart Institute, Houston, Texas, United States

H

Huan-Hsing Chiang

The Texas Heart Institute, Houston, Texas, United States

L

Logan Butler

The Texas Heart Institute, Houston, Texas, United States

C

Camila Hochman Mendez

The Texas Heart Institute, Houston, Texas, United States

D

Darren Woodside

The Texas Heart Institute, Houston, Texas, United States

T

Thomas Luescher

University of Zurich, Zurich, Switzerland

A

Alon Azares

The Texas Heart Institute, Houston, Texas, United States